CLINICAL AND LABORA TORY CHARACTERISTICS OF COVID-19 COURSE IN PA TIENTS OVER 60 YEARS OLD

Purpose of the work: to research clinical and laboratory parameters, the proportion of concomitant pathology and complications that affect the severe course of COVID-19 in people over 60 years old. Materials and methods: a retrospective analysis of medical documents of 134 patients over 60 years old with COVID-19, proceeding with concomitant pathology and complications, was carried out. The patients were divided into two age categories: elderly people (from 60 to 74 years old) - 89 patients, as well as elderly people (from 75 to 90 years old) - 45 patients. Results and discussion: the severe unfavorable course of COVID-19 was associated with the presence of concomitant diseases from the cardiovascular system (coronary heart disease, arterial hypertension, myocardial infarction) - 115 (85.8%). Concomitant pathology of the respiratory system was noted in 16 (11.9%) cases, the presence of type 2 diabetes mellitus - in 36 (26.9%), oncopathology - in 8 (5.9%) cases. The development of complications also influenced the course of the disease, the most common manifestation was pneumonia, leading to DN and ARDS. According to the existing classification, lung damage according to CT data ranged from 10 to 90%. Persistent leukopenia, which was observed in patients transferred to the ICU, was a formidable sign of a severe course of the disease. Valuable laboratory criteria were neutrophilia, lymphocytopenia, increased levels of D-dimer, C-reactive protein.

coronavirus infection COVID-19, concomitant diseases, old and senile age, complications

1. Кардиальное повреждение у пациентов с коронавирусной инфекцией COVID-19 /Н. Г. Потешкина, М. А. Лысенко, Е. А. Ковалевская и др. //Артериальная гипертензия. - 2020. - Т. 26, №3. - С. 277-287.

2. Клинический протокол диагностики и лечения МЗ РК Коронависрусная инфекция COVID-19» 10-я редакция с изменениями от 15.07.2020.

3. Новая коронавирусная инфекция SARS-COV-2 у пациентов пожилого и старческого возраста: особенности профилактики, диагностики и лечения, согласованная позиция экспертов российской ассоциации геронтологов и гериатров /О. Н. Ткачева, Ю. В. Котовская, Л. А. Алексанян и др. //Кардиоваскулярная терапия и профилактика. - 2020. - Т. 19, №3. - С. 127-151.

4. Прогнозирование тяжелого течения заболевания у пациентов с вирусными пневмониями предположительно вызванными COVID-19 /В. А. Прищепенко, Г. И. Юпатов, В. К. Окулич и др. //Вестник ВГМУ. - 2020. - Т.19, №3. - С. 69-78.

5. COVID-19 in diabetic patients: Related risks and specifics of management /Laura Orioli, Michel P. Hermans, Jean-Paul //Elsevier Public Health Emergency Collection. - 2020. - P. 101-109/

6. Remuzzi A. COVID-19 and Italy: what next? /A. Remuzzi, G. Remuzzi //Lancet. - 2020. -V. 395. - P. 1225-1228.

7. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China /R. Porcheddu, C. Serra, D. Kelvin et al. //J. Infect. Dev. Ctries. - 2020. - V. 29. - P. 125-128.

8. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020 http://weekly.chinacdc.cn/en/artide/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51